The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Market Cap
573 million
PE Ratio
-
Beta (volatility)
2.39
Earnings Per Share
-1.01
About
ISIN : US04335A1051
Its lead product candidates are ARV-110, a proteolysis targeting chimera...
Price
Performance Comparison
| Arvinas Inc | |
|---|---|
| 1 year return |
-69 %
|
| 5 years return |
-71 %
|
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 0.94 | 0 % |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| 2.18 | -2.14 | 5.69 |
Price–Earnings Ratio History
The Price–Earnings Ratio history is not available for this stock.
Dividend History
It looks like no dividends is being distributed for this stock...
Number of Outstanding Shares
Financials
Year-over-Year growth
Profitability
Health
News
Arvinas, Inc. (NASDAQ:ARVN) Stake Jumps 194% at XTX Topco
8/23/2025
Arvinas, Pfizer’s Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment
8/18/2025
Pfizer and Arvinas' breast cancer therapy to be reviewed by FDA
8/8/2025
FDA accepts vepdegestrant NDA for ESR1-mutated breast cancer
8/8/2025
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
8/8/2025
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
8/8/2025
Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles
8/6/2025
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
8/6/2025
Here are the major earnings before the open Wednesday
8/5/2025
ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised
8/5/2025
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2025 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.